Table 2.
Cancer Cell Line | Inhibition Rate by 1 (%) | Inhibition Rate by Adriamycin (%) |
---|---|---|
human leukemic cell line HL-60 | 68.8 | 70.0 |
human hepatoma cell line BEL-7402 | 31.7 | 79.3 |
human lung adenocarcinoma cell line A549 | 55.9 | 80.8 |
Cancer Cell Line | Inhibition Rate by 1 (%) | Inhibition Rate by Adriamycin (%) |
---|---|---|
human leukemic cell line HL-60 | 68.8 | 70.0 |
human hepatoma cell line BEL-7402 | 31.7 | 79.3 |
human lung adenocarcinoma cell line A549 | 55.9 | 80.8 |